John Oyler, Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 4,940 shares at $270.38 ($1.3M) on 2026-06-08, disclosed to the SEC on 2026-06-10.
Open-market sale of $1.3M ONC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $270.38 | 3,820 | $1.0M | 77.3% |
| 2 | $271.14 | 1,120 | $304K | 22.7% |
| Total | $270.56 avg | 4,940 | $1.3M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |